期刊文献+

阿立哌唑合并小剂量奥氮平治疗精神分裂症的对照研究 被引量:7

下载PDF
导出
摘要 本文对阿立哌唑合并奥氮平治疗精神分裂症的疗效和安全性进行研究,报告如下。1对象和方法为2008年4月至2010年6月我院符合CCMD-3精神分裂症诊断标准住院患者;PANSS总分≥60分;入组前2周未服用过抗精神病药。排除合并严重躯体疾病、老人、儿童、妊娠及哺乳期妇女,药物过敏者。共60例,按入院时间随机分为研究组(阿立哌唑合并小剂量奥氮平)32例,男14例,
出处 《临床精神医学杂志》 2013年第1期72-72,共1页 Journal of Clinical Psychiatry
  • 相关文献

参考文献1

二级参考文献8

  • 1沈渔邮.精神病学[M].4版.北京:人民卫生出版社,2006:426-429.
  • 2Gaszer P, Makkos Z. Clozapine treatment of schizophrenia [ J ]. Neuropsychophamacol, 1999,1 (26) : 28 - 30.
  • 3Melter HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia international suicide prevention trial (interSePT) [ J ]. Arch Gen Psychiat, 2003,60 ( 1 ) : s2 - 91.
  • 4Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability inshort - term, Placebo - controlled trials [J ]. Schizophr Res, 2003,61 : 123 - 136.
  • 5Lieberman J, Carson WH, Saha AR, et al. Meta - analysis of the efficacy of Aripiprazole in. Schizophrenia [ J ]. Int J Neuropsychopharmaco1,2002,5 (suppl) : 186.
  • 6Gentile S. Long - term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis[ J ]. Drug Saf, 2006,29(4) :303 -319.
  • 7McQuade RD, Stock E, Marcus R, et al. A comparison of weight chang during treatment with olanzapine or aripiprazole: results form a randomized, double- blind study[ J ]. J Chn Psychiatry, 2004,65 ( Suppl 18 ) :47 - 56.
  • 8Nasrallah H. A review of the effect of atypical antipsychotics on weight[ J ]. Psychoneuroendocrinology, 2003,28 ( Suppl 1 ) : 83 - 96.

共引文献12

同被引文献41

  • 1秦玉花,康文秀,宋丽.利培酮合并阿普唑仑治疗急性期精神分裂症的对照分析[J].中国健康心理学杂志,2005,13(6):444-445. 被引量:1
  • 2黄悦.神经性厌食症的药物治疗[J].中国心理卫生杂志,2007,21(10):724-726. 被引量:2
  • 3陆峥,蔡军,陈静,朱俊娟,薛振康,郭珍,熊祥玉,姚佩芬,杨晓敏,唐文忠,徐鹤定,江开达.碳酸锂合并典型和非典型抗精神病药治疗双相障碍躁狂发作的1年随访[J].中国神经精神疾病杂志,2007,33(11):696-698. 被引量:16
  • 4Gunlicks ML, Weissman MM. Change in child psychopa- thology with improvement in parental depression: a sys- tematic review[J]. J Am Acad Child Adolesc Psychiatry, 2008,47(4) : 379.
  • 5Dunn V, Goodyer IM. Longitudinal investigation into ch- ildhood and adolescence onset depression:psychiatric out- come in early adulthood[J]. Br J Psychiatry, 2006, 188 : 216.
  • 6Sikich L, Frazier JA, McClellan J, et al.Double-blind com- parison of first-and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study[J]. Am J Psychiatry, 2008,165(1) : 1 420.
  • 7Toren P, Ratner S, Laor N, et al. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophre- nia and comorhid disorders in children and adolescents[J]. Dru~,Saf,2004,27(14):1 135.
  • 8Maughan B, Collishaw S, Strlngans A. Depression inchildhood and adolescence[J]. J Can Acad Child Adolesc Psychiatry, 2013,22 ( 1 ) : 35.
  • 9Hetrick SE, McKenzie JE, Cox GR, et al. Newer genera- tion antidepressants for depressive disorders in children and adolescents[J]. Cochrane Database Syst Rev, 2012, doi : 10.1002/14651858.CD004851.
  • 10Emslie G J, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depres- sive disorder: a randomized, multicenter, double-blind, placebo-controlled trial[J]. JAm Acad .Child Adolesc Psy- chiatry, 2006,45(6) : 709.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部